Biphasic allergic reaction - Symptoms, Causes, Treatment & Prevention

```html

Overview

A biphasic allergic reaction (also called a biphasic anaphylaxis) is a two‑stage systemic allergic response. After the initial reaction resolves—usually within minutes to a few hours—a second wave of symptoms can reappear without further exposure to the trigger. This second phase can occur anywhere from 1 to 72 hours after the first event, most commonly between 4 and 12 hours.

Anyone who experiences a classic anaphylactic reaction (e.g., due to food, insect venom, medications, or latex) is at risk for a biphasic pattern, but certain factors increase the likelihood:

• Severe or rapidly progressing initial anaphylaxis
• Delayed or inadequate treatment with epinephrine
• Underlying asthma or chronic lung disease
• Older age (≥65 years) and comorbid cardiovascular disease

Exact prevalence is difficult to pinpoint because many cases are not reported, but studies suggest that 1%–20% of anaphylaxis patients develop a biphasic reaction (Mayo Clinic, 2023). In emergency‑department cohorts, the rate averages about 5–10% when rigorous follow‑up is performed.

Symptoms

The symptom profile mirrors that of a primary anaphylactic reaction, but it can be milder, more localized, or, in rare cases, more severe. Symptoms may appear suddenly after a period of apparent stability.

General (systemic) symptoms

• Skin: urticaria (hives), flushing, itching, angio‑edema (swelling of lips, eyelids, tongue)
• Respiratory: wheezing, shortness of breath, throat tightness, hoarseness, cough
• Cardiovascular: rapid pulse, hypotension, dizziness, fainting, chest discomfort
• Gastrointestinal: nausea, vomiting, abdominal cramps, diarrhea
• Neurologic: feeling of impending doom, anxiety, confusion

Possible variations in the second phase

• Re‑emergence of hives after they had resolved
• New‑onset wheezing or bronchospasm even if lungs were clear initially
• Delayed hypotension without obvious skin changes
• Isolated abdominal pain or vomiting without cutaneous signs

Causes and Risk Factors

Because a biphasic reaction is a continuation of the immune cascade that triggered the first anaphylaxis, the underlying causes are identical.

Common triggers

• Food allergens: peanuts, tree nuts, shellfish, fish, milk, egg, sesame
• Insect venom: honey‑bee, wasp, hornet, fire ant
• Medications: antibiotics (penicillins, sulfonamides), non‑steroidal anti‑inflammatory drugs (NSAIDs), radiologic contrast agents, chemotherapy agents
• Latex and other materials: gloves, catheters, medical devices

Risk factors for a biphasic pattern

1. Severity of the initial reaction – > 30% body‑surface‑area urticaria, hypotension, or respiratory compromise increases odds (CDC, 2022).
2. Delayed epinephrine administration – receiving epinephrine > 15 minutes after symptom onset nearly doubles risk.
3. High serum tryptase (> 15 µg/L) during the first phase, indicating massive mast‑cell activation.
4. Concurrent asthma – airway hyperreactivity predisposes to delayed bronchospasm.
5. Age > 65 years or presence of cardiovascular disease – reduced physiologic reserve can mask early warning signs.

Diagnosis

Diagnosis is clinical, based on a documented initial anaphylaxis followed by a recurrence of symptoms after a symptom‑free interval, without new exposure to the allergen.

Key diagnostic steps

1. Detailed history – timing of first and second symptom sets, trigger identification, prior reactions, epinephrine use.
2. Physical examination – assess airway, breathing, circulation, skin, and gastrointestinal signs during the second phase.
3. Laboratory testing (optional)
   • Serum tryptase – draw at 0–2 hours after the second wave and compare with baseline (if available). Elevated levels help confirm mast‑cell degranulation.
   • Complete blood count, electrolytes – useful if hypotension or shock is present.
4. Allergy testing – skin prick or specific IgE testing to identify the culprit allergen; performed after the acute phase (usually ≥ 4 weeks).

There is no separate “biphasic test”; the diagnosis rests on recognizing the pattern and ensuring the patient received appropriate treatment for the first reaction.

Treatment Options

Treatment of the biphasic reaction follows the same algorithm as primary anaphylaxis, with a focus on rapid epinephrine administration and close observation.

Emergency medications

• Epinephrine (adrenaline) – 0.01 mg/kg intramuscularly (max 0.5 mg for adults) into the mid‑outer thigh. Repeat every 5–15 minutes if symptoms persist.
• Antihistamines – H1 blockers (diphenhydramine 25–50 mg oral/IV) for cutaneous symptoms; H2 blockers (ranitidine or famotidine) can be added.
• Corticosteroids – historically given to prevent recurrence, but evidence for preventing biphasic reactions is limited. Still commonly used (e.g., methylprednisolone 1 mg/kg IV).
• Bronchodilators – inhaled albuterol for wheezing or bronchospasm.
• Fluid resuscitation – isotonic crystalloids (e.g., normal saline) for hypotension.

Procedures

• Airway management – supplemental oxygen, nebulized epinephrine, or advanced airway (intubation) if airway compromise progresses.
• Continuous cardiac monitoring – especially in patients with cardiovascular disease.

Observation period

Guidelines from the American College of Allergy, Asthma & Immunology (ACAAI) recommend a minimum observation of 4–6 hours after symptom resolution for low‑risk patients, and up to **24 hours** for high‑risk individuals (severe initial reaction, asthma, or delayed epinephrine).

Long‑term management

• Prescription of an auto‑injectable epinephrine device (EpiPen®, Auvi‑Q®, etc.) with proper training.
• Referral to an allergist for identification of the trigger and consideration of immunotherapy (e.g., venom desensitization or oral immunotherapy for foods).
• Education on recognizing early signs of recurrence.

Living with Biphasic Allergic Reaction

Even after the acute episode resolves, many patients feel anxious about a possible “second wave.” The following strategies help maintain confidence and safety.

Action plan

1. Carry two epinephrine auto‑injectors at all times.
2. Keep a written emergency plan (including trigger, dosage, and emergency contacts) in your wallet or phone.
3. Notify close contacts—family, friends, coworkers—about your condition and how to use epinephrine.

Medication reminders

• Set daily alarms to check that both auto‑injectors are unexpired.
• Replace any device that is past its expiration date (usually 12–18 months).

Lifestyle adaptations

• Food safety: read labels, ask about ingredients when eating out, consider a “food allergy card” for restaurants.
• Insect avoidance: wear long sleeves, avoid strong fragrances, keep food covered outdoors.
• Medication vigilance: wear a medical alert bracelet, carry a list of drug allergies.

Follow‑up care

Schedule an appointment with an allergist within 2–4 weeks of the reaction. Discuss:

• Allergy testing results.
• Potential for desensitization therapy.
• Adjustment of asthma or chronic disease medications that may influence reaction severity.

Prevention

Preventing the initial anaphylaxis is the most effective way to avoid biphasic reactions.

• Identify and avoid triggers: thorough allergy testing, meticulous food label reading, and environmental control measures.
• Prompt epinephrine use: educate patients to inject at the first sign of a systemic reaction—delay reduces effectiveness and raises biphasic risk.
• Asthma control: maintain inhaled corticosteroid therapy and avoid known broncho‑triggers.
• Vaccination awareness: for patients with known latex or vaccine component allergies, discuss alternatives with the healthcare provider.
• Medication review: ask pharmacists to flag cross‑reactive drugs (e.g., certain antibiotics and NSAIDs).

Complications

If a biphasic reaction is missed or inadequately treated, serious complications can develop:

• Refractory hypotension leading to shock and organ hypoperfusion.
• Severe airway obstruction requiring emergent intubation or surgical airway.
• Cardiac arrhythmias or myocardial ischemia, especially in older adults.
• Neurologic injury from prolonged hypoxia.
• Psychologic impact – anxiety, post‑traumatic stress, or phobia of food/venom exposure.

Timely epinephrine and observation dramatically reduce these risks (CDC, 2022).

When to Seek Emergency Care

---

**References** (accessed April 2026)

• Mayo Clinic. “Anaphylaxis.” Mayo Clinic Proceedings, 2023.
• Centers for Disease Control and Prevention (CDC). “Anaphylaxis and Biphasic Reactions.” 2022.
• National Institutes of Health (NIH). “Guidelines for the Management of Anaphylaxis.” 2021.
• World Health Organization (WHO). “Allergy and Anaphylaxis.” 2020.
• Cleveland Clinic. “Biphasic Anaphylaxis: What You Need to Know.” 2023.
• American College of Allergy, Asthma & Immunology (ACAAI). “Practice Parameter for Anaphylaxis.” 2022.

```